Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Presenilin-1 | 43 | 2024 | 666 | 10.030 |
Why?
|
Alzheimer Disease | 82 | 2024 | 8759 | 8.070 |
Why?
|
Colombia | 22 | 2024 | 287 | 2.810 |
Why?
|
CADASIL | 7 | 2022 | 83 | 2.590 |
Why?
|
Neuropsychological Tests | 30 | 2024 | 7140 | 2.200 |
Why?
|
tau Proteins | 21 | 2024 | 2144 | 2.010 |
Why?
|
Neurofilament Proteins | 3 | 2024 | 336 | 2.000 |
Why?
|
Apolipoprotein E3 | 6 | 2024 | 105 | 1.900 |
Why?
|
Amyloid beta-Peptides | 32 | 2024 | 3914 | 1.860 |
Why?
|
Heterozygote | 14 | 2024 | 2798 | 1.780 |
Why?
|
Amyloid | 9 | 2024 | 854 | 1.550 |
Why?
|
Memory Disorders | 6 | 2022 | 1200 | 1.420 |
Why?
|
Positron-Emission Tomography | 33 | 2024 | 6669 | 1.400 |
Why?
|
Brain | 31 | 2024 | 27360 | 1.220 |
Why?
|
Mutation | 25 | 2024 | 30238 | 1.040 |
Why?
|
Mental Recall | 4 | 2020 | 1226 | 0.960 |
Why?
|
Tauopathies | 4 | 2024 | 328 | 0.960 |
Why?
|
Apolipoprotein E4 | 4 | 2024 | 712 | 0.910 |
Why?
|
Evoked Potentials | 5 | 2018 | 1058 | 0.870 |
Why?
|
Cognition | 17 | 2024 | 7073 | 0.820 |
Why?
|
Dementia, Vascular | 2 | 2021 | 125 | 0.820 |
Why?
|
Presenilins | 1 | 2021 | 51 | 0.740 |
Why?
|
Agnosia | 1 | 2020 | 67 | 0.700 |
Why?
|
Memory | 4 | 2020 | 2208 | 0.690 |
Why?
|
Loneliness | 1 | 2022 | 211 | 0.690 |
Why?
|
Olfaction Disorders | 1 | 2022 | 225 | 0.650 |
Why?
|
Cross-Sectional Studies | 23 | 2024 | 26379 | 0.620 |
Why?
|
Memory, Short-Term | 3 | 2020 | 1008 | 0.610 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 259 | 0.600 |
Why?
|
Magnetic Resonance Imaging | 27 | 2024 | 36743 | 0.570 |
Why?
|
Cognition Disorders | 6 | 2021 | 3980 | 0.560 |
Why?
|
Semantics | 2 | 2020 | 618 | 0.550 |
Why?
|
Apolipoprotein E2 | 3 | 2024 | 134 | 0.550 |
Why?
|
Executive Function | 3 | 2020 | 1401 | 0.540 |
Why?
|
Neurodegenerative Diseases | 3 | 2020 | 1095 | 0.530 |
Why?
|
Humans | 106 | 2024 | 768166 | 0.510 |
Why?
|
Dementia | 5 | 2022 | 2740 | 0.500 |
Why?
|
Peptide Fragments | 4 | 2019 | 5151 | 0.490 |
Why?
|
Age of Onset | 6 | 2024 | 3347 | 0.470 |
Why?
|
Reaction Time | 1 | 2020 | 2101 | 0.450 |
Why?
|
Latin America | 5 | 2022 | 416 | 0.440 |
Why?
|
Psychometrics | 2 | 2021 | 3063 | 0.440 |
Why?
|
Adult | 42 | 2024 | 223646 | 0.430 |
Why?
|
Male | 58 | 2024 | 364719 | 0.410 |
Why?
|
Corpus Striatum | 1 | 2019 | 1224 | 0.410 |
Why?
|
Female | 56 | 2024 | 397192 | 0.380 |
Why?
|
Homozygote | 3 | 2022 | 1779 | 0.380 |
Why?
|
Aniline Compounds | 6 | 2021 | 1094 | 0.350 |
Why?
|
Sex Characteristics | 2 | 2022 | 2650 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 7 | 2021 | 18065 | 0.320 |
Why?
|
Middle Aged | 33 | 2024 | 223492 | 0.310 |
Why?
|
Genes, Dominant | 3 | 2024 | 855 | 0.300 |
Why?
|
Pandemics | 5 | 2022 | 8748 | 0.300 |
Why?
|
Verbal Behavior | 2 | 2012 | 336 | 0.290 |
Why?
|
Longitudinal Studies | 10 | 2024 | 14783 | 0.260 |
Why?
|
Visual Perception | 1 | 2015 | 1402 | 0.260 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15454 | 0.250 |
Why?
|
Asymptomatic Diseases | 3 | 2019 | 590 | 0.250 |
Why?
|
Secondary Prevention | 1 | 2011 | 1474 | 0.250 |
Why?
|
Genotype | 4 | 2024 | 13045 | 0.240 |
Why?
|
Hippocampus | 4 | 2023 | 3785 | 0.240 |
Why?
|
Early Diagnosis | 4 | 2021 | 1194 | 0.240 |
Why?
|
Apolipoproteins E | 4 | 2023 | 1461 | 0.240 |
Why?
|
Ethylene Glycols | 2 | 2019 | 198 | 0.240 |
Why?
|
Aged | 26 | 2024 | 171504 | 0.230 |
Why?
|
Young Adult | 16 | 2022 | 60066 | 0.220 |
Why?
|
Self Report | 5 | 2024 | 3773 | 0.210 |
Why?
|
Locus Coeruleus | 2 | 2022 | 243 | 0.210 |
Why?
|
Apathy | 1 | 2024 | 107 | 0.210 |
Why?
|
Retinal Artery | 2 | 2021 | 109 | 0.200 |
Why?
|
Amyloidogenic Proteins | 1 | 2022 | 153 | 0.200 |
Why?
|
Family | 2 | 2024 | 3209 | 0.190 |
Why?
|
Disease Progression | 6 | 2021 | 13671 | 0.190 |
Why?
|
Apolipoproteins | 1 | 2023 | 328 | 0.180 |
Why?
|
Personality Tests | 1 | 2021 | 80 | 0.180 |
Why?
|
Retinal Vein | 1 | 2021 | 47 | 0.180 |
Why?
|
Depression | 4 | 2024 | 8230 | 0.170 |
Why?
|
Intermediate Filaments | 1 | 2020 | 171 | 0.170 |
Why?
|
Independent Living | 2 | 2021 | 584 | 0.170 |
Why?
|
Cohort Studies | 7 | 2021 | 41754 | 0.170 |
Why?
|
Diffusion Tensor Imaging | 2 | 2021 | 2420 | 0.160 |
Why?
|
Spain | 1 | 2020 | 485 | 0.160 |
Why?
|
Ileum | 1 | 2021 | 558 | 0.150 |
Why?
|
Educational Status | 2 | 2023 | 2515 | 0.150 |
Why?
|
Cerebral Cortex | 2 | 2012 | 5812 | 0.150 |
Why?
|
Botulinum Toxins, Type A | 1 | 2021 | 238 | 0.140 |
Why?
|
Receptors, Notch | 2 | 2020 | 751 | 0.140 |
Why?
|
Risk Reduction Behavior | 2 | 2021 | 1119 | 0.140 |
Why?
|
Sex Factors | 2 | 2021 | 10632 | 0.140 |
Why?
|
Electroencephalography | 4 | 2019 | 6314 | 0.140 |
Why?
|
Aging | 3 | 2024 | 8744 | 0.140 |
Why?
|
Urinary Incontinence | 1 | 2021 | 490 | 0.140 |
Why?
|
Photic Stimulation | 2 | 2015 | 1997 | 0.130 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 500 | 0.130 |
Why?
|
Aged, 80 and over | 14 | 2024 | 59629 | 0.130 |
Why?
|
Thiazoles | 3 | 2018 | 1542 | 0.130 |
Why?
|
Carbolines | 1 | 2018 | 295 | 0.130 |
Why?
|
Preventive Health Services | 1 | 2021 | 570 | 0.130 |
Why?
|
Adolescent | 8 | 2021 | 89169 | 0.120 |
Why?
|
Brain Mapping | 4 | 2015 | 6685 | 0.120 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 1001 | 0.120 |
Why?
|
Urinary Bladder | 1 | 2021 | 1157 | 0.120 |
Why?
|
Down Syndrome | 1 | 2023 | 919 | 0.110 |
Why?
|
Language | 1 | 2003 | 1557 | 0.110 |
Why?
|
Atrophy | 2 | 2023 | 1646 | 0.110 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1140 | 0.110 |
Why?
|
Exercise Therapy | 1 | 2020 | 939 | 0.110 |
Why?
|
Pedigree | 2 | 2019 | 4539 | 0.110 |
Why?
|
Child | 7 | 2021 | 80917 | 0.100 |
Why?
|
Mycophenolic Acid | 2 | 2007 | 348 | 0.100 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20227 | 0.100 |
Why?
|
Cues | 1 | 2017 | 878 | 0.100 |
Why?
|
South America | 1 | 2011 | 180 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2019 | 2592 | 0.090 |
Why?
|
Discriminant Analysis | 1 | 2011 | 222 | 0.090 |
Why?
|
Boston | 2 | 2021 | 9374 | 0.090 |
Why?
|
Age Factors | 2 | 2018 | 18412 | 0.090 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2018 | 1489 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2023 | 4413 | 0.090 |
Why?
|
Organ Size | 1 | 2015 | 2267 | 0.090 |
Why?
|
Psychomotor Performance | 1 | 2018 | 1892 | 0.080 |
Why?
|
Anxiety | 1 | 2024 | 4672 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 16045 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4260 | 0.080 |
Why?
|
Association Learning | 1 | 2010 | 221 | 0.080 |
Why?
|
Registries | 3 | 2020 | 8375 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2019 | 2735 | 0.080 |
Why?
|
Life Style | 1 | 2020 | 3932 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 2 | 2017 | 4063 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2024 | 81762 | 0.070 |
Why?
|
Attention | 1 | 2018 | 2424 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5955 | 0.070 |
Why?
|
Socioeconomic Factors | 3 | 2020 | 7852 | 0.070 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2957 | 0.070 |
Why?
|
Risk Factors | 5 | 2022 | 74944 | 0.070 |
Why?
|
Plaque, Amyloid | 2 | 2021 | 769 | 0.070 |
Why?
|
Stroke | 2 | 2019 | 9755 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4120 | 0.070 |
Why?
|
Ischemia | 2 | 2007 | 1900 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2862 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6611 | 0.060 |
Why?
|
Chromosome Aberrations | 1 | 2011 | 1778 | 0.060 |
Why?
|
Task Performance and Analysis | 1 | 2009 | 771 | 0.060 |
Why?
|
Intergenerational Relations | 1 | 2004 | 68 | 0.060 |
Why?
|
United States | 2 | 2022 | 73039 | 0.060 |
Why?
|
Functional Laterality | 1 | 2010 | 2264 | 0.060 |
Why?
|
Walking | 2 | 2021 | 1201 | 0.060 |
Why?
|
Mice | 4 | 2023 | 82029 | 0.050 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2023 | 111 | 0.050 |
Why?
|
Pattern Recognition, Visual | 1 | 2009 | 826 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3415 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2011 | 6229 | 0.050 |
Why?
|
Acute Kidney Injury | 2 | 2007 | 1942 | 0.050 |
Why?
|
Immunosuppressive Agents | 2 | 2007 | 4206 | 0.050 |
Why?
|
Animals | 7 | 2023 | 169246 | 0.050 |
Why?
|
Neuropsychology | 1 | 2022 | 110 | 0.050 |
Why?
|
Temporal Lobe | 1 | 2009 | 1726 | 0.050 |
Why?
|
Phenotype | 4 | 2021 | 16726 | 0.050 |
Why?
|
Caribbean Region | 1 | 2021 | 193 | 0.040 |
Why?
|
Caudate Nucleus | 1 | 2002 | 391 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2010 | 9015 | 0.040 |
Why?
|
Signal Transduction | 1 | 2023 | 23645 | 0.040 |
Why?
|
Oxygen | 1 | 2010 | 4270 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7214 | 0.040 |
Why?
|
Fibrinogen | 1 | 2022 | 891 | 0.040 |
Why?
|
Urologic Surgical Procedures | 1 | 2021 | 281 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15832 | 0.040 |
Why?
|
Injections | 1 | 2021 | 840 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2004 | 3729 | 0.040 |
Why?
|
Photography | 1 | 2021 | 537 | 0.040 |
Why?
|
Self Efficacy | 1 | 2021 | 643 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 2017 | 315 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1643 | 0.030 |
Why?
|
Endostatins | 1 | 2016 | 167 | 0.030 |
Why?
|
Reference Values | 2 | 2019 | 4938 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2479 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2023 | 1596 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1376 | 0.030 |
Why?
|
Drug Discovery | 1 | 2021 | 1068 | 0.030 |
Why?
|
Phosphorylation | 1 | 2023 | 8317 | 0.030 |
Why?
|
Kidney | 1 | 2007 | 7064 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1027 | 0.020 |
Why?
|
Reoperation | 1 | 2021 | 4329 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5315 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2744 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2663 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2016 | 1493 | 0.020 |
Why?
|
Fluorine Radioisotopes | 1 | 2012 | 425 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2013 | 958 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2018 | 2359 | 0.020 |
Why?
|
Time Factors | 1 | 2011 | 40218 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 22291 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6894 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54926 | 0.020 |
Why?
|
Neural Pathways | 1 | 2018 | 3117 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6029 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2002 | 4262 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 6211 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8054 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9561 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2007 | 8128 | 0.010 |
Why?
|
Sampling Studies | 1 | 2004 | 615 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10873 | 0.010 |
Why?
|
Biomedical Research | 1 | 2018 | 3463 | 0.010 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2004 | 305 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3912 | 0.010 |
Why?
|
Renal Circulation | 1 | 2002 | 291 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2002 | 623 | 0.010 |
Why?
|
Tobacco Use Disorder | 1 | 2004 | 708 | 0.010 |
Why?
|
Rats | 2 | 2007 | 23760 | 0.010 |
Why?
|
Intelligence | 1 | 2002 | 926 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18349 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65371 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15662 | 0.010 |
Why?
|
Alcoholism | 1 | 2004 | 1980 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10590 | 0.010 |
Why?
|
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(75)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_